| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Strategy Officer | Chief Operating Officer | Chief Operating Officer
1 company
Tessari Eben is a Chief Strategy Officer at KNSA. Recent filings cover 0 purchases and 34 sales. Those positions are worth an estimated $1.1M at current prices.
Our model assigns Tessari Eben a below-average insider score of 32/100, based on 27 past trades. Over a 12-month horizon, 5.9% of those trades were profitable, with an average 12-month return of -75.4%.
Tessari Eben's largest disclosed position is in KNSA as Chief Strategy Officer, worth about $1.1M. The recent filings there lean toward selling, a net 628,733 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 12,048 | $41.56 | $500,714.88 | -42.0% | +11.9% | - | |
| Nov 26, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 200 | $42.89 | $8,578.00 | -0.9% | +2.3% | - | |
| Nov 17, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 12,470 | $41.24 | $514,224.10 | -35.4% | +9.6% | - | |
| Oct 14, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 12,368 | $37.67 | $465,843.22 | -30.1% | +8.5% | +108.1% | |
| Sep 29, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 42,000 | $38.33 | $1,609,860.00 | -54.9% | +5.7% | +95.3% | |
| Sep 15, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 16,400 | $36.46 | $597,975.80 | -32.2% | +13.6% | +105.6% | |
| Sep 5, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 98,660 | $35.54 | $3,506,277.66 | -68.9% | +14.8% | +118.2% | |
| Sep 3, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 15,091 | $35.50 | $535,730.50 | -25.3% | +12.9% | +126.8% | |
| Aug 18, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 16,200 | $33.77 | $547,141.00 | -28.7% | +22.8% | +135.7% | |
| Aug 5, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Chief Operating Officer | Sale+OE10b5-1 | 138,614 | $33.20 | $4,602,369.80 | -73.5% | +13.3% | +136.1% |